Litigation Details for Sorrento Therapeutics, Inc. and Official Committee of Unsecured Creditors (Bankr. S.D. Tex. 2023)

✉ Email this page to a colleague

Docket	⤷ Try a Trial	Date Filed	2023-02-13
Court	United States Bankruptcy Court, S.D. Texas	Date Terminated
Cause		Assigned To	Christopher Lopez
Jury Demand		Referred To
Parties	SCINTILLA PHARMACEUTICALS, INC.
Patents	10,336,829
Attorneys	Ryan E Manns
Firms	Milbank L.L.P.
Link to Docket	External link to docket

The biologic drug covered by the patent cited in this case is ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2023-05-25	710	Schedule A/B AND Schedule D AND Schedule E/F AND Schedule G AND Schedule H	$0.00 None Undetermined Patent-10,336,829 INTRACELLULAR DELIVERY COMPOUNDS …Institute Office of Patent Counsel The Scripps Research Institute Office of Patent Counsel 10550… (Where available) 60. Patents, copyrights, trademarks, and trade secrets 60.1… Patents, Copyrights, Trademarks, and Trade Secrets …Book Value Valuation Method Current Value Patent-004020071-0001 APPLICATOR DEVICE FOR A FLUID DELIVERY	External link to document
2023-05-29	720		$0.00 N/A Undetermined Patent-10,336,829 INTRACELLULAR DELIVERY COMPOUNDS …an in-license is if someone has a patent and Sorrento uses the patent through a license for developing … Undetermined Patent-037855 ANTIGEN BINDING PROTEINS THAT BIND PD-L1-Eurasian Patent Organization …Undetermined Patent-2563450 DEVICE FOR DELIVERY OF RHEUMATOID ARTHRITIS MEDICATION-European Patent Convention… Undetermined Patent-2563451 MEDICAL DEVICES FOR DELIVERY OF siRNA-European Patent Convention	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document